These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16282089)

  • 41. The first methadone clinic in Beijing.
    Humeniuk R; Ali R
    Drug Alcohol Rev; 2005 May; 24(3):285-7. PubMed ID: 16096132
    [No Abstract]   [Full Text] [Related]  

  • 42. Adoption of naltrexone to treat alcohol dependence.
    Fuller BE; Rieckmann T; McCarty D; Smith KW; Levine H
    J Subst Abuse Treat; 2005 Apr; 28(3):273-80. PubMed ID: 15857728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review.
    Johansson BA; Berglund M; Lindgren A
    Addiction; 2006 Apr; 101(4):491-503. PubMed ID: 16548929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of depot naltrexone under legal coercion: the case for caution.
    Hall W; Capps B; Carter A
    Addiction; 2008 Dec; 103(12):1922-4. PubMed ID: 19469728
    [No Abstract]   [Full Text] [Related]  

  • 45. Medications development: successes and challenges.
    Vocci F; Ling W
    Pharmacol Ther; 2005 Oct; 108(1):94-108. PubMed ID: 16083966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R;
    Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.
    Burdon WM; Dang J; Prendergast ML; Messina NP; Farabee D
    Subst Abuse Treat Prev Policy; 2007 May; 2():16. PubMed ID: 17504540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Drug addiction in young prison inmates with and without attention deficit hyperactivity disorder (ADHD)].
    Retz W; Retz-Junginger P; Schneider M; Scherk H; Hengesch G; Rösler M
    Fortschr Neurol Psychiatr; 2007 May; 75(5):285-92. PubMed ID: 16586260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prison medicine.
    Greenberg MJ
    Am Fam Physician; 1988 Jul; 38(1):167-70. PubMed ID: 3394600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medication-assisted treatment research with criminal justice populations: challenges of implementation.
    Gordon MS; Kinlock TW; Miller PM
    Behav Sci Law; 2011; 29(6):829-45. PubMed ID: 22086665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Substance dependence and level of treatment need among recently-incarcerated prisoners.
    Rounds-Bryant JL; Baker L
    Am J Drug Alcohol Abuse; 2007; 33(4):557-61. PubMed ID: 17668341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
    Friedmann PD; Hoskinson R; Gordon M; Schwartz R; Kinlock T; Knight K; Flynn PM; Welsh WN; Stein LA; Sacks S; O'Connell DJ; Knudsen HK; Shafer MS; Hall E; Frisman LK;
    Subst Abus; 2012; 33(1):9-18. PubMed ID: 22263709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What is important in drug misuse treatment?
    Seivewright NA; Greenwood J
    Lancet; 1996 Feb; 347(8998):373-6. PubMed ID: 8598706
    [No Abstract]   [Full Text] [Related]  

  • 54. Addiction and the community. (Narcotic substitution therapy).
    Taylor WJ; Chambers CD; Bowling CE
    Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924
    [No Abstract]   [Full Text] [Related]  

  • 55. Factors predicting unmet health services needs among incarcerated substance users.
    Narevic E; Garrity TF; Schoenberg NE; Hiller ML; Webster JM; Leukefeld CG; Staton Tindall M
    Subst Use Misuse; 2006; 41(8):1077-94. PubMed ID: 16798677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What's happening in hard-drug rehabilitation?
    Walls RT; Gulkus SP
    Rehabil Lit; 1973 Jan; 34(1):2-6. PubMed ID: 4683507
    [No Abstract]   [Full Text] [Related]  

  • 57. Attention deficit hyperactivity disorder in prison: a treatment protocol.
    Appelbaum KL
    J Am Acad Psychiatry Law; 2009; 37(1):45-9. PubMed ID: 19297632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 28. Methadone maintenance and its implication for theories of narcotic addiction.
    Dole VP; Nyswander ME
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():359-66. PubMed ID: 5723803
    [No Abstract]   [Full Text] [Related]  

  • 59. [Management of drug addiction in France (a short history)].
    Chossegros P
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S44-50. PubMed ID: 17965635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Problem severity and motivation for treatment in incarcerated substance abusers.
    Hiller ML; Narevic E; Webster JM; Rosen P; Staton M; Leukefeld C; Garrity TF; Kayo R
    Subst Use Misuse; 2009; 44(1):28-41. PubMed ID: 19137481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.